COMMONWEALTH OF AUSTRALIA
Department of Health
Therapeutic Goods Administration
THERAPEUTIC GOODS ACT 1989
Sections 14 and 14A Notice
On 11 December 2015, a delegate of the Secretary of the Department of Health, on the application of Aspen Pharmacare Pty Ltd, consented under sections 14 and 14A of the Therapeutic Goods Act 1989 (the Act) to the supply of
- CARTIA LOW DOSE ASPIRIN 100mg tablet blister pack reformulation [AUST R 192506]
that does not conform with the requirements of the requirements of paragraph 3(2)(g) of the Therapeutic Goods Order No. 69 – General requirements for labels for medicine, in that the product labels do not include all of the new warning statements that will be required by the legislative instrument made by the Minister under subsection 3(5A) of the Act from 12 December 2015.
The consent is effective from 11 December 2015 until 31 December 2016.
The consent is subject to the following conditions:
- the labels to which this consent applies are those previously approved by the TGA for this product.